16 employees
Amplimmune is a product-driven company offering immune-based biologics to treat patients with cancer, autoimmunity, and infectious diseases.
2006
$20M
from 2 investors over 2 rounds
Amplimmun raised $20M on January 1, 2006
Investors: InterWest Partners and Wellcome Trust